Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kleist

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
European Journal of Clinical Pharmacology|July 29, 1998
Voglibose has no effect on the pharmacokinetics of hydrochlorothiazideP Kleist, Y Suzuki, T Thomsen, et al.
Digestion|January 1, 1995
Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserveB Göke, H Fuder, G Wieckhorst, et al.
Current Medical Research and Opinion|January 5, 2002
Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery diseaseB R Winkelmann, B O Boehm, M Nauck, et al.
European Journal of Clinical Pharmacology|January 1, 1997
The alpha-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarinH Fuder, P Kleist, M Birkel, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
European Journal of Clinical Pharmacology|July 29, 1998
Voglibose has no effect on the pharmacokinetics of hydrochlorothiazideP Kleist, Y Suzuki, T Thomsen, et al.
Digestion|January 1, 1995
Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserveB Göke, H Fuder, G Wieckhorst, et al.
Current Medical Research and Opinion|January 5, 2002
Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery diseaseB R Winkelmann, B O Boehm, M Nauck, et al.
European Journal of Clinical Pharmacology|January 1, 1997
The alpha-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarinH Fuder, P Kleist, M Birkel, et al.
Pageof 2